Physician

Paul Andrew Garfinkle, M.D.

According to 2025 Medicare claims, Paul Garfinkle, M.D. (NPI: 1144297060) practices ophthalmology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is OHIO EYE ALLIANCE, INC. (NPI: 1912974825; TIN: 34-1794374) and primary practice location at 44601-3515.

Garfinkle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 4,733 HCPCS/CPT codes, and received $366,923 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,449 prescription claims across 550 beneficiaries totaling $177,572 in drug costs, led by Lumigan (Bimatoprost). 2018 DME data shows 11 claims. Open Payments data shows 28 records totaling $784. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $82,196 to $177,572. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	578	3,249	$311,189
2016	632	3,649	$403,865
2017	595	3,227	$372,325
2018	528	3,156	$413,370
2019	551	3,254	$448,044
2020	476	2,981	$331,187
2021	464	2,703	$325,114
2022	448	2,695	$338,091
2023	407	4,622	$377,679
2024	526	4,733	$366,923

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	219	837	$82,196
2016	200	878	$72,452
2017	226	821	$83,699
2018	187	579	$57,924
2019	199	617	$77,955
2020	191	555	$75,697
2021	220	590	$97,105
2022	253	673	$106,075
2023	303	722	$115,379
2024	550	1,449	$177,572

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	11	11	$562
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	189	209	$72
92012	Established patient problem focused exam of visual system	177	297	$56
92134	Imaging of retina	158	374	$26
92250	Photography of the retina	89	95	$25
92133	Imaging of optic nerve	87	87	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	64	4,273	$35,631
Restasis	Cyclosporine	23	1,170	$22,243
Vyzulta	Latanoprostene Bunod	46	1,921	$16,676
Cyclosporine	Cyclosporine	12	1,080	$12,960
Rocklatan	Netarsudil Mesylat/Latanoprost	14	707	$8,245

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$784	Apellis Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul Andrew Garfinkle, M.D.?

Tedicare shows public-source Medicare data for Paul Andrew Garfinkle, M.D. (NPI 1144297060), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Andrew Garfinkle, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul Andrew Garfinkle, M.D.?

Paul Andrew Garfinkle, M.D. is linked to OHIO EYE ALLIANCE, INC. (billing NPI 1912974825) in the available physician profile data.

Does Paul Andrew Garfinkle, M.D. have Open Payments data?

Paul Andrew Garfinkle, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.